Power illness prevention and administration platform Lark Well being introduced will probably be accessible by means of CVS Caremark’s Level Options Administration program.
CVS Caremark clients could have the power to entry Lark’s teaching applications, together with the corporate’s GLP-1 price containment and weight problems administration choices, by means of CVS Caremark’s platform.
In a LinkedIn submit, Lark mentioned it can tailor a holistic program that’s scalable, accessible 24/7 and constructed upon particular employer wants, together with medical price financial savings, habits change-driven weight reduction options for acceptable members and predictive modeling to extend insights into personalised GLP-1 administration and commencement.
Lark Well being provides applications to assist forestall and handle hypertension and diabetes. The Lark app can be utilized with related units, comparable to scales, blood stress screens and blood glucose screens. The app can be used to speak with Lark coaches.
“Employers are responding to large demand for GLP-1 medicines and weight administration amongst workers and given the prices of those medication, they want versatile options that match their members’ wants,” Julia Hu, Lark Well being CEO and cofounder, mentioned on LinkedIn.
THE LARGER TREND
In 2024, Lark Well being appointed Darren Eckberg as chief progress officer to supervise the growth of the corporate’s AI-enabled GLP-1 cost-containment expertise.
Eckberg beforehand held govt positions at EnvisionRx/Ceremony Support, Specific Scripts, Prime Therapeutics and IngenioRx/Anthem.
In 2022, Lark Well being developed an AI-enabled platform aimed toward stopping and managing atherosclerotic heart problems and coronary artery illness in partnership with Roche Diagnostics.
In 2021, Lark Well being secured $100 million in a Sequence D funding spherical. Deerfield Administration Firm led the increase, with participation from PFM Well being Sciences and returning buyers Franklin Templeton, King River Capital, Castlepeak, IPD, Olive Tree Capital and Marvell Expertise cofounder Weili Dai.
